Management of vitiligo patients and attitude of dermatologists towards vitiligo

European Journal of Dermatology

Volumn 14, Issue 3, 2004, Pages 177-181

  Ongenae, Katia ^a   Van Geel, Nanny ^a   De Schepper, Sofie ^a   Haeghen, Yves Vander ^a   Naeyaert, Jean Marie ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Management; Treatment; Vitiligo

Indexed keywords

ATTITUDE; BELGIUM; CORRELATION ANALYSIS; DISEASE SEVERITY; DOCTOR PATIENT RELATION; HEALTH SURVEY; HUMAN; INFORMATION; MEDICAL SPECIALIST; QUESTIONNAIRE; REVIEW; VITILIGO;

ACADEMIC MEDICAL CENTERS; ADULT; ATTITUDE OF HEALTH PERSONNEL; BELGIUM; DERMATOLOGY; FEMALE; HUMANS; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS; QUESTIONNAIRES; VITILIGO;

EID: 2942620409     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Kent G, Al'Abadie M. Factors affecting responses on Dermatology Life Quality Index items among vitiligo sufferers. Clin Exp Dermatol 1996; 21: 330-3.
2. Porter JR, Beuf AH, Lerner AB, Nordlund JJ. Psychosocial effect of vitiligo: a comparison of vitiligo patients with normal subjects, with psoriasis patients, and with patients with other pigmentary disorders. J Am Acad Dermatol 1986; 15: 220-4.
3. Ongenae K, van Geel N, De Schepper S, Naeyaert JM. Effect of vitiligo on self-reported health-related quality of life. Submitted publication.
4. Kent G, Al'Abadie M. Psychologic effects of vitiligo: o critical incident analysis. J Am Acad Dermatol 1996; 35: 895-8.
5. Porter JR, Beuf AH, Lerner AB, Nordlund JJ. The effect of vitiligo on sexual relationships. J Am Acad Dermatol 1990; 22: 221-2.
6. Porter JP, Beuf AH, Nordlund JJ, Lerner AB: Psychological reaction to chronic skin disorders. A study of patients with vitiligo. Gen Hosp Psychiatry 1979; 1: 73-7.
7. Agarwol G. Vitiligo: an underestimated problem. Family Practice 1997; 15: S19-S23.
8. Porter JP, Beuf AH, Nordlund JJ, Lerner AB. Personal responses to vitiligo. Arch Dermatol 1978; 114: 1348-85.
9. Porter JR, Beuf AH, Lerner AB, Nordlund JJ. Response to cosmetic disfigurement: patients with vitiligo. Cutis 1987; 39: 493-4.
10. Grimes PE, Kenney JA. Should vitiligo be treated? Cutis 1983; 32: 343-6.
11. Njoo MD, Bossuyt PMM, Westerhof W. Management of vitiligo. Results of a questionnaire among dermatologists in The Netherlands. Int J Dermatol 1999; 38: 866-72.
12. Njoo MD, Spuls Ph I, Bos JD, Westerhof W, Bossuyt PMM. Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature. Arch Dermatol 1998; 134: 1532-40.
13. Westerhaf W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B (311 nm) versus topical PUVA. Arch Dermatol 1997; 133: 1525-8.
14. Njoo MD, Westerhof W, Bos JD, Bossuyt PMM. A systematic review of autologous transplantation methods in vitiligo. Arch Dermatol 1998; 134: 1543-9.
15. Parsad D, Saini R, Nagpal R. Calcipotriol in vitiligo: a preliminary study. Pediatr Dermatol 1999; 16: 317-20.
16. Spencer JM, Nossa R, Ajmeri J. Treatment of vitiligo with the 308-nm excimer laser: a pilot study. J Am Acad Dermatol 2002; 46: 727-31.
17. Travis LB, Weinberg JM, Silverberg NB. Successful treatment of vitiligo with 0.1% tacrolimus ointment. Arch Dermatol 2003; 139: 571-4.
18. Grimes PE, Soriano T, Dytoc MT. Topical tacrolimus for repigmentation of vitiligo. J Am Acad Dermatol 2002; 47: 789-91.
19. van Geel N, Ongenae K, De Mil M, Naeyaert JM. Modified technique of autologous noncultured epidermal cell transplantation for repigmenting vitiligo: a pilot study. Dermatol Surg 2001; 27: 873-6.
20. Lepe V, Moncada B, Castanedo-Cazares JP, Torres-Alvarez MB, Ortiz CA, Torres-Rubolcava AB. A Double-blind Randomized Trial of 0.1% Tacrolimus vs 0.05% Clobetasol for the Treatment of Childhood Vitiligo. Arch Dermatol 2003; 139: 581-5.
21. Ermis O, Alpsoy E, Cetin L, Yilmaz E. Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study. Br J Dermatol 2001; 145: 472-5.
22. Yalcin B, Sahin S, Bukulmez G, Karadumon A, Atakan N, Akan T, Kolemen F. Experience with calcipotriol as adjunctive treatment for vitiligo in patients who do not respond to PUVA olone: a preliminary study. J Am Acad Dermatol 2001; 44: 634-7.
23. Kose O, Riza Gur A, Kurumlu Z, Erol E. Calcipotriol ointment versus clobetasol ointment in localized vitiligo: an open, comparative clinical triol. Int J Dermatol 2002; 41: 616-8.
24. van Geel N, Ongenae K, De Mil M, Vander Haeghen Y, Vervaet C, Naeyaert JM. Double blind placebo controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo. Arch Dermatol accepted.
25. Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol 2000; 42: 245-53.
26. Njoo MD, Westerhof W, Bos JD Bossuyt PMM. The development of guidelines for the treatment of vitiligo. Arch Dermatol 1999; 135: 1514-21.